Elsevier

Ophthalmology

Volume 120, Issue 2, February 2013, Pages 227-233
Ophthalmology

Original article
Surgical Outcomes and Safety of Femtosecond Laser Cataract Surgery: A Prospective Study of 1500 Consecutive Cases

https://doi.org/10.1016/j.ophtha.2012.10.026Get rights and content

Objective

To report the surgical outcomes and safety of femtosecond (FS) laser cataract surgery (LCS) with greater surgeon experience, modified techniques, and improved technology.

Design

Prospective, interventional case series.

Participants

Fifteen hundred consecutive eyes undergoing FS laser cataract and refractive lens exchange surgery in a single group private practice.

Intervention

Femtosecond LCS.

Methods

All eyes undergoing LCS between April 2011 and March 2012 were included in the study. Cases underwent anterior capsulotomy, lens fragmentation, and corneal incisions with the Alcon/LenSx FS laser (Alcon/LenSx, Aliso Viejo, CA). The procedure was completed by phacoemulsification and insertion of an intraocular lens. The cases were divided into 2 groups: Group 1, initial experience consisting of the first 200 cases; and group 2, the subsequent 1300 cases performed by the same surgeons.

Main Outcome Measures

Intraoperative complication rates and comparison between groups.

Results

Both groups were comparable for baseline demographic parameters. Anterior capsule tears occurred in 4% and 0.31% of eyes, posterior capsule tears in 3.5% and 0.31% of eyes, and posterior lens dislocation in 2% and 0% of eyes in groups 1 group 2, respectively (P<0.001 for all comparisons). Number of docking attempts per case (1.5 vs 1.05), incidence of post-laser pupillary constriction (9.5% vs 1.23%), and anterior capsular tags (10.5% vs 1.61%) were significantly lower in group 2 (P<0.001 for all comparisons).

Conclusions

In the authors' experience, the surgical outcomes and safety of LCS improved significantly with greater surgeon experience, development of modified techniques, and improved technology.

Financial Disclosure(s)

Proprietary or commercial disclosure may be found after the references.

Section snippets

Patients and Methods

This was a single-center, prospective, consecutive cohort study. Ethics approval was obtained from the local human research ethics committee for the evaluation of the safety and success of the LenSx laser system (Alcon, Fort Worth, TX). The study was a part of a prospective, multicenter, nonrandomized, postmarket evaluation undertaken after local regulatory approval was obtained for clinical use of the LenSx system. An in-depth discussion about the risks and benefits of the procedure was

Results

A total of 1500 consecutive cataract/refractive lens exchange surgeries performed with the LenSx FS laser were included in the study. Baseline and demographic parameters were comparable between the 2 groups (Table 2). A comparison of complications between the 2 groups is listed in Table 3. In summary, the incidence of major complications (anterior capsule tears, posterior capsule tears, and posterior lens dislocation) in group 2 was statistically lower compared with the initial group (0.31% vs

Discussion

This prospective, single-center study evaluates safety and surgical outcomes of FS LCS performed after the initial learning curve. We found a significantly lower rate of complications once the surgeons became familiar with the technology. The rate of major capsular complications (anterior and posterior tears) decreased from 7.5% to 0.62% with no cases of dropped nuclei or capsular block syndrome.

Preoperative demographic and clinical parameters were comparable between the 2 groups with no

Acknowledgments

The authors thank Drs. Colin Chan, Simon Chen, Mark Jacobs, Paul Hughes, and David Ng for allowing access to patient data.

References (40)

Cited by (212)

  • Application of Femtosecond Laser in Challenging Cataract Cases

    2023, Asia-Pacific Journal of Ophthalmology
View all citing articles on Scopus

Manuscript no. 2012-851.

Financial Disclosure(s): The authors have no proprietary or commercial interest in any materials discussed in this article.

Michael Lawless is a member of the Medical Advisory Board of Alcon LenSx, USA.

View full text